Literature DB >> 1674518

CD2 antigen mediated activation of the guanine nucleotide binding proteins p21ras in human T lymphocytes.

J D Graves1, J Downward, S Rayter, P Warne, A L Tutt, M Glennie, D A Cantrell.   

Abstract

T cell stimulation via the TCR complex (TCR/CD3 complex) results in activation of the guanine nucleotide binding proteins encoded by the ras protooncogenes (p21ras). In the present study we show that the activation state of p21ras in T lymphocytes can also be controlled by triggering of the CD2 Ag. The activation state of p21ras is controlled by GTP levels on p21ras. In T cells stimulation of protein kinase C is able to induce an accumulation of "active" p21ras-GTP complexes due to an inhibitory effect of protein kinase C stimulation on the intrinsic GTPase activity of p21ras. The regulatory effect of protein kinase C on p21ras GTPase activity appears to be mediated via regulation of GAP, the GTPase activating protein of p21ras. In the present report, we demonstrate that the TCR/CD3 complex and the CD2 Ag control the accumulation of p21ras-GTP complexes via a regulatory effect on p21ras GTPase activity. The TCR/CD3 complex and CD2 Ag are also able to control the cellular activity of GAP. These data demonstrate that p21ras is part of the signal transduction responses controlled by the CD2 Ag, and reveal that the TCR/CD3 complex and CD2 Ag control the activation state of p21ras via a similar mechanism.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1674518

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

Review 1.  Regulation of integrin function by T cell activation: points of convergence and divergence.

Authors:  T Zell; W J Kivens; S A Kellermann; Y Shimizu
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 2.  The Ras signal transduction pathway.

Authors:  R Khosravi-Far; C J Der
Journal:  Cancer Metastasis Rev       Date:  1994-03       Impact factor: 9.264

3.  Role of protein kinase C in T-cell antigen receptor regulation of p21ras: evidence that two p21ras regulatory pathways coexist in T cells.

Authors:  M Izquierdo; J Downward; J D Graves; D A Cantrell
Journal:  Mol Cell Biol       Date:  1992-07       Impact factor: 4.272

4.  Disparate effects of phorbol esters, CD3 and the costimulatory receptors CD2 and CD28 on RANTES secretion by human T lymphocytes.

Authors:  Y Sotsios; P J Blair; J Westwick; S G Ward
Journal:  Immunology       Date:  2000-09       Impact factor: 7.397

5.  Identification of a proline-rich sequence in the CD2 cytoplasmic domain critical for regulation of integrin-mediated adhesion and activation of phosphoinositide 3-kinase.

Authors:  W J Kivens; S W Hunt; J L Mobley; T Zell; C L Dell; B E Bierer; Y Shimizu
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

6.  Regulation of Ras signal transduction during T cell development and activation.

Authors:  Philip E Lapinski; Philip D King
Journal:  Am J Clin Exp Immunol       Date:  2012

7.  Activation of Ras in vitro and in intact fibroblasts by the Vav guanine nucleotide exchange protein.

Authors:  E Gulbins; K M Coggeshall; C Langlet; G Baier; N Bonnefoy-Berard; P Burn; A Wittinghofer; S Katzav; A Altman
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

8.  Epidermal growth factor regulates the exchange rate of guanine nucleotides on p21ras in fibroblasts.

Authors:  L Buday; J Downward
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

9.  The novel cyclic dinucleotide 3'-5' cyclic diguanylic acid binds to p21ras and enhances DNA synthesis but not cell replication in the Molt 4 cell line.

Authors:  D Amikam; O Steinberger; T Shkolnik; Z Ben-Ishai
Journal:  Biochem J       Date:  1995-11-01       Impact factor: 3.857

10.  p21ras and calcineurin synergize to regulate the nuclear factor of activated T cells.

Authors:  M Woodrow; N A Clipstone; D Cantrell
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.